Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01137240 · ClinicalTrials.gov registry record

Gastrointestinal Dysfunction in Children Affected With Mitochondrial Disorders

A clinical trial of Gastrointestinal Dysfunction and Mitochondrial Disorders, sponsored by The University of Texas Health Science Center, Houston.

Completed
Registry status
26
Enrollment target
1
Study location

NCT01137240: Completed study of Gastrointestinal Dysfunction and Mitochondrial Disorders, sponsored by The University of Texas Health Science Center, Houston.

NCT01137240 is a study of Gastrointestinal Dysfunction and Mitochondrial Disorders that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 26 participants, below the 77-participant average among 4 other Gastrointestinal Dysfunction trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01137240, a study of Gastrointestinal Dysfunction and Mitochondrial Disorders, has completed, sponsored by The University of Texas Health Science Center, Houston.

COMPLETED
Registry status
26 participants
Enrollment target
1
Study location

Study Summary

Hypothesis: Many patients with underlying mitochondrial disorders have feeding problems because of poor gastrointestinal motility; feeding problems lead to growth impairment and many affected children are malnourished.

Interventions

  • PROCEDURE gastric emptying scan

Study Locations (1)

Texas

  • University of Texas- Houston Health Sceince Center - Houston

Trial Details

FieldValue
Enrollment Target 26 participants
Start Date 2010-06
Est. Completion 2011-03

What the finished NCT01137240 record still lists

NCT01137240 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 77-participant average among 4 other Gastrointestinal Dysfunction trials with a reported enrollment target (66% lower).

The record links to 2 conditions, with Gastrointestinal Dysfunction appearing as the primary indexed condition, and to 1 intervention - of which gastric emptying scan is the first listed.

NCT01137240 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT01137240 about?

NCT01137240 is a clinical study titled "Gastrointestinal Dysfunction in Children Affected With Mitochondrial Disorders". Hypothesis: Many patients with underlying mitochondrial disorders have feeding problems because of poor gastrointestinal motility; feeding problems lead to growth impairment and many affected children are malnourished.

What is the current status of trial NCT01137240?

This trial is currently completed. The enrollment target is 26 participants. The study started on 2010-06. Estimated completion is 2011-03.

What conditions does trial NCT01137240 study?

This clinical trial studies the following conditions: Gastrointestinal Dysfunction, Mitochondrial Disorders.

What interventions are being tested in trial NCT01137240?

The interventions under investigation include: gastric emptying scan (PROCEDURE).

Who is sponsoring clinical trial NCT01137240?

This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01137240 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Gastrointestinal Dysfunction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02646475 · 26 participants · Phase 1

    Metabolic Effects of Angiotensin-(1-7)

  • NCT03603223 · 26 participants · Phase 2

    Pembrolizumab in Treating Participants With Leukoplakia

  • NCT04063592 · 26 participants · NA

    AMI Construction in Lower Extremity Residual Limbs

  • NCT04906460 · 26 participants · Phase 1

    Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01137240, the US trial registry maintained by the National Library of Medicine. NCT01137240 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.